Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
P & T : a Peer-Reviewed Journal for Formulary Management
|
November 2, 2017
Correcting Naldemedine (Symproic) Product Summary
Marc Cataldo
Addiction (Abingdon, England)
|
June 9, 2016
Arrhythmia associated with buprenorphine and methadone reported to the Food and Drug Administration
Marc Cataldo
Infectious Diseases and Therapy
|
September 28, 2021
In Vitro Evaluation of the Virucidal Activity of Different Povidone-Iodine Formulations Against Murine and Human Coronaviruses
Manjunath Shet, Rosa Hong, David Igo, et al.
BMC Oral Health
|
February 26, 2022
In vitro inactivation of SARS-CoV-2 using a povidone-iodine oral rinse
Manjunath Shet, Jonna Westover, Rosa Hong, et al.
Toxicology and Applied Pharmacology
|
December 7, 2023
Evaluation of dermal toxicity and toxicokinetics of povidone‑iodine in Göttingen minipigs
Evangeline Priya Eddy, Manjunath S Shet, Marc Cataldo, et al.
CNS Drugs
|
May 31, 2021
Effect of a Multi-Layer, Extended-Release Methylphenidate Formulation (PRC-063) on Sleep in Adults with ADHD: A Randomized, Double-Blind, Forced-Dose, Placebo-Controlled Trial Followed by a 6-month Open-Label Extension
Margaret Danielle Weiss, Craig Surman, Atul Khullar, et al.
Journal of Attention Disorders
|
July 5, 2022
Analysis of Daily Sleep Diary Measures From Multilayer Extended-Release Methylphenidate (PRC-063) Studies in Children and Adults With ADHD
Marc Cataldo, Graeme Donnelly, Andrew J Cutler, et al.
Journal of Child and Adolescent Psychopharmacology
|
October 29, 2021
Effect of a Multilayer, Extended-Release Methylphenidate Formulation (PRC-063) on Sleep in Adolescents with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Fixed-Dose, Placebo-Controlled Trial Followed by a 6-Month Open-Label Follow-Up
Margaret Danielle Weiss, Craig Surman, Atul Khullar, et al.
Journal of Attention Disorders
|
May 5, 2026
An Exploratory Study of Functional Outcome in Stimulant Treatment of ADHD in Adults
Margaret D Weiss, Jeffrey H Newcorn, Pratap Chokka, et al.
Journal of Attention Disorders
|
January 20, 2024
Drivers and Barriers to Tolerable and Effective Treatment for ADHD: The Importance of Treatment Perseverance and Duration of Effect
Nate Way, Jaromir Mikl, Marc Cataldo, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
P & T : a Peer-Reviewed Journal for Formulary Management
|
November 2, 2017
Correcting Naldemedine (Symproic) Product Summary
Marc Cataldo
Addiction (Abingdon, England)
|
June 9, 2016
Arrhythmia associated with buprenorphine and methadone reported to the Food and Drug Administration
Marc Cataldo
Infectious Diseases and Therapy
|
September 28, 2021
In Vitro Evaluation of the Virucidal Activity of Different Povidone-Iodine Formulations Against Murine and Human Coronaviruses
Manjunath Shet, Rosa Hong, David Igo, et al.
BMC Oral Health
|
February 26, 2022
In vitro inactivation of SARS-CoV-2 using a povidone-iodine oral rinse
Manjunath Shet, Jonna Westover, Rosa Hong, et al.
Toxicology and Applied Pharmacology
|
December 7, 2023
Evaluation of dermal toxicity and toxicokinetics of povidone‑iodine in Göttingen minipigs
Evangeline Priya Eddy, Manjunath S Shet, Marc Cataldo, et al.
CNS Drugs
|
May 31, 2021
Effect of a Multi-Layer, Extended-Release Methylphenidate Formulation (PRC-063) on Sleep in Adults with ADHD: A Randomized, Double-Blind, Forced-Dose, Placebo-Controlled Trial Followed by a 6-month Open-Label Extension
Margaret Danielle Weiss, Craig Surman, Atul Khullar, et al.
Journal of Attention Disorders
|
July 5, 2022
Analysis of Daily Sleep Diary Measures From Multilayer Extended-Release Methylphenidate (PRC-063) Studies in Children and Adults With ADHD
Marc Cataldo, Graeme Donnelly, Andrew J Cutler, et al.
Journal of Child and Adolescent Psychopharmacology
|
October 29, 2021
Effect of a Multilayer, Extended-Release Methylphenidate Formulation (PRC-063) on Sleep in Adolescents with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Fixed-Dose, Placebo-Controlled Trial Followed by a 6-Month Open-Label Follow-Up
Margaret Danielle Weiss, Craig Surman, Atul Khullar, et al.
Journal of Attention Disorders
|
May 5, 2026
An Exploratory Study of Functional Outcome in Stimulant Treatment of ADHD in Adults
Margaret D Weiss, Jeffrey H Newcorn, Pratap Chokka, et al.
Journal of Attention Disorders
|
January 20, 2024
Drivers and Barriers to Tolerable and Effective Treatment for ADHD: The Importance of Treatment Perseverance and Duration of Effect
Nate Way, Jaromir Mikl, Marc Cataldo, et al.
Page
of 1